High CXCL9 and CXCL10 levels inhibit cytolytic CD8+ T cell expression of CXCR3 in hepatocellular carcinomas, and this, in turn, limits lymphocyte recruitment and tumor defense [23]. This evidence concerns the gene CXCL9 and hepatocellular carcinoma.